ICU Medical (ICUI) Stock Forecast & Price Target

ICU Medical is a leading player in the infusion therapy market with a strong portfolio of products and services. The company has recently completed strategic acquisitions, which have strengthened its position in the industry. With a focus on expanding its product pipeline, competitive wins, and growth in its key segments, we expect ICU Medical to sustain its mid-single digit revenue growth and deliver strong earnings growth in the coming years. Its projected free cash flow inflection and attractive valuation make it a compelling investment opportunity for the long-term.

ICU Medical is continuing to outperform expectations with better-than-expected revenue, EBITDA, and EPS growth. The company's strategic acquisitions have also positively impacted its overall performance, as seen in its strong revenue growth in all three reporting segments. However, tariff impacts and excluded tariff refunds may have artificially boosted earnings, and it remains heavily reliant on the US market.